Patents/Assignees

CELLA THERAPEUTICS, LLC

1 patent in portfolio

US12128104utility2024
Drug Delivery Systems Comprising a Neurotrophic Agent, an Apoptosis Signaling Fragment Inhibitor (FAS) or FAS Ligand (FASL) Inhibitor, a Tumor Necrosis Factor-alpha (tnf-alpha) or TNF Receptor Inhibitor, a Mitochondrial Peptide, an Oligonucleotide, a Chemokine Inhibitor, or a Cysteine-aspartic Protease Inhibitor
0 cites